- €79.05m
- €76.75m
- €65.57m
- 92
- 30
- 53
- 61
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 66.7 | 76 | 70.4 | 66.6 | 65.6 |
Cost of Revenue | |||||
Gross Profit | 39.6 | 49.1 | 45.1 | 45.2 | 40.9 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 64.4 | 66.6 | 63.4 | 60.8 | 61.9 |
Operating Profit | 2.28 | 9.44 | 7 | 5.8 | 3.67 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.59 | 9.06 | 6.38 | 5.83 | 3.62 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.07 | 6.13 | 4.33 | 4.2 | 2.69 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1.09 | 5.86 | 3.95 | 4.08 | 3.05 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.09 | 5.86 | 3.95 | 4.08 | 3.06 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.139 | 1.9 | 1.37 | 1.4 | 1.12 |
Dividends per Share |